Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

626 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4-65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in Germany.
Aydin I, May M, Pisano F, Mpofu-Maetzig N, Grode L, Parekh S, Pujari P, Shewale S, Desai S, Sharma H, Rao H, Gautam M, Gairola S, Shaligram U. Aydin I, et al. Among authors: parekh s. Vaccine. 2023 Oct 10:S0264-410X(23)01157-X. doi: 10.1016/j.vaccine.2023.09.060. Online ahead of print. Vaccine. 2023. PMID: 37827966
Safety and immunogenicity of diphtheria-tetanus-pertussis vaccine and hepatitis B vaccine as a new tetravalent combination (DTwP/HB) administered alone and at separate sites (DTwP and HB) including comparison with standard commercially available combination vaccine in Indian infants 6-14 weeks of age.
Sharma HJ, Dutta AK, Joshi SM, Malik S, Bhardwaj S, Namjoshi GS, Parekh SS. Sharma HJ, et al. Among authors: parekh ss. Hum Vaccin. 2009 May;5(5):310-4. doi: 10.4161/hv.5.5.6909. Epub 2009 May 1. Hum Vaccin. 2009. PMID: 18849664 Clinical Trial.
Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children.
Sharma HJ, Yadav S, Lalwani SK, Kapre SV, Jadhav SS, Chakravarty A, Parekh SS, Palkar S, Bhardwaj SH, Namjoshi GS, Verma V. Sharma HJ, et al. Among authors: parekh ss. Hum Vaccin. 2011 Apr;7(4):451-7. doi: 10.4161/hv.7.4.14208. Epub 2011 Apr 1. Hum Vaccin. 2011. PMID: 21403463 Clinical Trial.
A phase III randomized, controlled study to assess and compare the immunogenicity and tolerability of single and multi-dose vials of DTwP-Hib, a fully liquid quadravalent vaccine and their comparison with TETRAct-Hib vaccine in Indian infants aged 6-14 weeks.
Sharma H, Yadav S, Patil V, Chacko B, Kapre S, Jadhav S, Ravetkar S, Bahl S, Parekh S, Chakravarty A, Ashtagi G, Prasath A. Sharma H, et al. Among authors: parekh s. Vaccine. 2011 Nov 8;29(48):8773-9. doi: 10.1016/j.vaccine.2011.09.093. Epub 2011 Oct 1. Vaccine. 2011. PMID: 21968445 Clinical Trial.
Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process.
Sharma HJ, Patil VD, Lalwani SK, Manglani MV, Ravichandran L, Kapre SV, Jadhav SS, Parekh SS, Ashtagi G, Malshe N, Palkar S, Wade M, Arunprasath TK, Kumar D, Shewale SD. Sharma HJ, et al. Among authors: parekh ss. Vaccine. 2012 Jan 11;30(3):510-6. doi: 10.1016/j.vaccine.2011.11.067. Epub 2011 Nov 26. Vaccine. 2012. PMID: 22119927 Clinical Trial.
626 results